StockData
Apyx Medical Corp logo

Apyx Medical Corp (APYX) stock

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3031% above fair value
$2.65−0.16 (-5.69%)

Close on Nov 16, 2026Market cap $111.63MP/E –Yield –

Apyx Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Apyx Medical's operating income for the twelve months ending Sep 30, 2026 was -$3.28M. For fiscal 2025 it was -$6.45M. The highest annual figure on record is $1.05M in fiscal 2012.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.45M–
FY2024Dec 31, 2024-$18.85M–
FY2023Dec 31, 2023-$17.26M–
FY2022Dec 31, 2022-$23.56M–
FY2021Dec 31, 2021-$14.45M–
FY2020Dec 31, 2020-$20.08M–
FY2019Dec 31, 2019-$20.87M–
FY2018Dec 31, 2018-$14.28M–
FY2017Dec 31, 2017-$13.89M–
FY2016Dec 31, 2016-$11.39M–
FY2015Dec 31, 2015-$6.99M–
FY2014Dec 31, 2014-$5.85M–
FY2013Dec 31, 2013-$3.67M-450.5%
FY2012Dec 31, 2012$1.05M–
FY2011Dec 31, 2011-$18.00K–
FY2010Dec 31, 2010-$2.75M-484.9%
FY2009Dec 31, 2009$715.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$571.00K–
Q2 FY2026Jun 30, 2026-$1.81M–
Q1 FY2026Mar 31, 2026-$911.00K–
Q4 FY2025Dec 31, 2025$11.00K–
Q3 FY2025Sep 30, 2025-$832.00K–
Q2 FY2025Jun 30, 2025-$2.57M–
Q1 FY2025Mar 31, 2025-$3.05M–
Q4 FY2024Dec 31, 2024-$3.05M–
Q3 FY2024Sep 30, 2024-$3.64M–
Q2 FY2024Jun 30, 2024-$5.55M–
Q1 FY2024Mar 31, 2024-$6.62M–
Q4 FY2023Dec 31, 2023-$5.78M–
Q3 FY2023Sep 30, 2023-$4.64M–
Q2 FY2023Jun 30, 2023-$1.24M–
Q1 FY2023Mar 31, 2023-$5.61M–
Q4 FY2022Dec 31, 2022-$5.93M–
Q3 FY2022Sep 30, 2022-$5.78M–
Q2 FY2022Jun 30, 2022-$5.98M–
Q1 FY2022Mar 31, 2022-$5.87M–
Q4 FY2021Dec 31, 2021-$1.69M–
Q3 FY2021Sep 30, 2021-$3.97M–
Q2 FY2021Jun 30, 2021-$4.04M–
Q1 FY2021Mar 31, 2021-$4.75M–
Q4 FY2020Dec 31, 2020-$2.05M–
Q3 FY2020Sep 30, 2020-$4.37M–
Q2 FY2020Jun 30, 2020-$6.17M–
Q1 FY2020Mar 31, 2020-$7.49M–
Q4 FY2019Dec 31, 2019-$5.96M–
Q3 FY2019Sep 30, 2019-$4.76M–
Q2 FY2019Jun 30, 2019-$4.42M–
Q1 FY2019Mar 31, 2019-$5.73M–
Q4 FY2018Dec 31, 2018-$5.84M–
Q3 FY2018Sep 30, 2018-$2.79M–
Q2 FY2018Jun 30, 2018-$2.93M–
Q1 FY2018Mar 31, 2018-$2.72M–
Q4 FY2017Dec 31, 2017-$3.24M–
Q3 FY2017Sep 30, 2017-$2.83M–
Q2 FY2017Jun 30, 2017-$1.31M–
Q1 FY2017Mar 31, 2017-$1.74M–
Q4 FY2016Dec 31, 2016-$8.64M–

More Apyx Medical figures

See a number that looks wrong?